Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients (Q64693842)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients |
clinical trial |
Statements
Certi-CMV (English)
0 references
Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients (English)
0 references
December 2008
0 references
December 2013
0 references
40
0 references
18 year
0 references